General Information of the Compound
Compound ID
CP0501678
Compound Name
2-[4-(4-bromo-phenyl)-pyridin-3-yl]-3-isobutyl-1-oxo-1lambda*4*-thiazolidin-4-one
    Show/Hide
Structure
Formula
C18H19BrN2O2S
Molecular Weight
407.333
Canonical SMILES
CC(C)CN1C(c2cnccc2-c2ccc(Br)cc2)S(=O)CC1=O
    Show/Hide
InChI
InChI=1S/C18H19BrN2O2S/c1-12(2)10-21-17(22)11-24(23)18(21)16-9-20-8-7-15(16)13-3-5-14(19)6-4-13/h3-9,12,18H,10-11H2,1-2H3
    Show/Hide
InChIKey
SCEQKECTMMQORQ-UHFFFAOYSA-N
Physicochemical Property
logP
3.7566
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
50.27
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44430918
ChEMBL ID
CHEMBL234273
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02031, Voltage-dependent N-type calcium channel subunit alpha-1B
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000016 IMR-32 Homo sapiens (Human)  1
1
IC50 = 3970 nM
   TI
   LI
   LO
   TS